newsfilter
← Latest News
Business Wire·

Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that data from the Phase 3 pivotal studies of investigational drug Crisaborole Topical Ointment, 2% will be presented at two upcoming medical meetings.